Dmitry Rogachev National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
Institute for Information Transmission Problems (the Kharkevich Institute, RAS), Moscow, Russian Federation.
Am J Clin Pathol. 2024 Aug 1;162(2):180-190. doi: 10.1093/ajcp/aqae020.
Mixed-phenotype acute leukemia (MPAL) is a rare disease associated with difficulties in the correct lineage assignment of leukemic cells. One of the least common subtypes within this category is characterized by the simultaneous presence of B- and T-lineage-defining antigens. Each case of suspected B/T MPAL should be considered in light of all available laboratory and clinical data to avoid misdiagnosis.
In this study, we describe 6 pediatric patients who presented with leukemic blasts bearing B- and T-lineage antigens at diagnosis, including their clinical, immunophenotypic, morphologic, and cytogenetic characteristics.
In 3 patients, more or less distinct populations of B- and T-lymphoid origin were found; the other 3 patients had a single mixed-phenotype blast population. All cases fulfilled the World Health Organization criteria, but not all of them turned out to be bona fide cases of B/T MPAL according to the available clinical and laboratory data. Found genetic lesions were helpful for the confirmation of MPAL instead of 2 concomitant tumors, but for a general B/T MPAL diagnosis, genetic studies provided the only descriptive data.
The accurate diagnosis of B/T MPAL requires a multidisciplinary approach combining high-tech laboratory methods and close cooperation between treating physicians and pathologists.
混合表型急性白血病(MPAL)是一种与白血病细胞的正确谱系归属困难相关的罕见疾病。在该类别中,最不常见的亚型之一的特征是同时存在 B 系和 T 系定义抗原。应根据所有可用的实验室和临床数据考虑每一例疑似 B/T-MPAL,以避免误诊。
在本研究中,我们描述了 6 例以诊断时存在 B 系和 T 系抗原的白血病原始细胞为特征的儿科患者,包括其临床、免疫表型、形态学和细胞遗传学特征。
在 3 例患者中,发现了或多或少明确的 B 系和 T 系淋巴细胞起源的群体;其他 3 例患者具有单一的混合表型原始细胞群体。所有病例均符合世界卫生组织标准,但并非所有病例根据现有临床和实验室数据均为真正的 B/T-MPAL 病例。发现的遗传病变有助于确认 MPAL 而不是 2 个同时发生的肿瘤,但对于一般的 B/T-MPAL 诊断,遗传研究仅提供描述性数据。
B/T-MPAL 的准确诊断需要结合高科技实验室方法和治疗医生与病理学家之间密切合作的多学科方法。